These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 6608013
21. Immunobiological properties of 1-butanol-extracted cell surface antigens. LeGrue SJ, Allison JP, Macek CM, Pellis NR, Kahan BD. Cancer Res; 1981 Oct; 41(10):3956-60. PubMed ID: 7026027 [Abstract] [Full Text] [Related]
22. Topographical distribution and association of tumor--associated antigens and their role in antigenicity in rat tumor cells. Moriuchi T. Hokkaido Igaku Zasshi; 1979 Sep; 54(5):487-99. PubMed ID: 93561 [Abstract] [Full Text] [Related]
24. [Reversion of the immunological eclipse and therapeutic vaccination against cancer in an experimental model]. Chiarella P, Vulcano M, Laborde E, Vermeulen M, Bruzzo J, Rearte B, Bustuoabad OD, Ruggiero RA. Medicina (B Aires); 2007 Sep; 67(1):44-8. PubMed ID: 17408020 [Abstract] [Full Text] [Related]
26. Immunity to a 3-methylcholanthrene-induced fibrosarcoma in the C57BL/6 mouse: in vivo analysis by the adoptive tumor neutralization test. Poupon MF, Lespinats G, Kolb JP, Payelle B. J Natl Cancer Inst; 1979 Apr; 62(4):989-94. PubMed ID: 311871 [Abstract] [Full Text] [Related]
27. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice. Vaage J. Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179 [No Abstract] [Full Text] [Related]
35. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice. Rios A, Simmons RL. Cancer Res; 1972 Jan 15; 32(1):16-21. PubMed ID: 4550256 [No Abstract] [Full Text] [Related]
36. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation. Jurin M, Suit HD. Cancer Res; 1974 Apr 15; 34(4):672-8. PubMed ID: 4814987 [No Abstract] [Full Text] [Related]
38. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration. Bracci L, Moschella F, Sestili P, La Sorsa V, Valentini M, Canini I, Baccarini S, Maccari S, Ramoni C, Belardelli F, Proietti E. Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):644-53. PubMed ID: 17255288 [Abstract] [Full Text] [Related]
39. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell]. Yamasaki T, Yamashita J, Handa H, Namba Y, Hanaoka M. No Shinkei Geka; 1984 Feb 15; 12(2):141-50. PubMed ID: 6609319 [Abstract] [Full Text] [Related]